For: | Habib S. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. World J Gastrointest Pathophysiol 2024; 15(2): 92791 [PMID: 38845820 DOI: 10.4291/wjgp.v15.i2.92791] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i2/92791.htm |
Number | Citing Articles |
1 |
Shahid Habib, Andrew Johnson. An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease. Exploration of Digestive Diseases 2024; : 459 doi: 10.37349/edd.2024.00061
|
2 |
Shahid Habib. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy. World Journal of Gastrointestinal Pathophysiology 2024; 15(4): 93606 doi: 10.4291/wjgp.v15.i4.93606
Abstract(327) |
Core Tip(342) |
Full Article(HTML)(2674)
|
Full Article with Cover (PDF)-138493K(63)
|
Audio-557K(8)
|
Peer-Review Report-170K(40)
|
Answering Reviewers-93K(37)
|
Supplementary Material-683K(46)
|
Full Article (PDF)-138263K(159)
|
Full Article (XML)-491K(35)
|
Times Cited (1)
|
Total Visits (4982)
|
Open
|
3 |
Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman. A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease. Biomedicines 2025; 13(3): 644 doi: 10.3390/biomedicines13030644
|
4 |
Ramasamy Selvarani, HoangVan Michelle Nguyen, Natesan Pazhanivel, Muthusamy Raman, Sunho Lee, Roman F. Wolf, Sathyaseelan S. Deepa, Arlan Richardson. The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet. GeroScience 2024; doi: 10.1007/s11357-024-01418-3
|
5 |
Barbara Toffoli, Consuelo Comar, Andrea Grillo, Vincenzo Barbato, Emanuele Vincis, Veronica Baldi, Silvia Berti, Teresa Volpato, Francesca Zorat, Saveria Lory Crocè, Giacomo Emmi, Bruno Fabris, Massimo Puato, Stella Bernardi. PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis. International Journal of Molecular Sciences 2025; 26(7): 3256 doi: 10.3390/ijms26073256
|
6 |
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos-Molina. Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.64
|
7 |
Neha Shah, Arun J. Sanyal. A Pragmatic Management Approach for Metabolic Dysfunction-Associated Steatosis and Steatohepatitis. American Journal of Gastroenterology 2025; 120(1): 75 doi: 10.14309/ajg.0000000000003215
|